Department of Molecular Microbiology and Immunology, University of Missouri School of Medicine, M616 Medical Sciences Building, Columbia, MO 65212, USA.
Department of Molecular Microbiology and Immunology, University of Missouri School of Medicine, M616 Medical Sciences Building, Columbia, MO 65212, USA; Department of Child Health, University of Missouri School of Medicine, M616 Medical Sciences Building, Columbia, MO 65212, USA; Department of Neurology, University of Missouri School of Medicine, M616 Medical Sciences Building, Columbia, MO 65212, USA.
J Neuroimmunol. 2014 Jan 15;266(1-2):49-55. doi: 10.1016/j.jneuroim.2013.09.022. Epub 2013 Oct 5.
F1 (SJL/J×C57BL/6) mice with MOG35-55-induced EAE recover from disease when treated with Ig-MOG carrying MOG35-55 peptide. However, Ig-PLP1, carrying PLP139-151, induced reduction of anti-MOG antibodies and exacerbated EAE. Herein, we show that Ig-PLP1 specifically reduces the frequency of B cells producing protective IgG2a/b anti-MOG antibodies. Surprisingly, these cells were marginal zone (MZ), rather than follicular (FO) or newly formed (NF), B cells and transfer of MZ B cells into sick mice nullified disease exacerbation by Ig-PLP1 in a complement dependent manner. These findings reveal a potential self-limiting regulatory mechanism involving auto-antibodies in MOG EAE.
SJL/J×C57BL/6 小鼠经 MOG35-55 诱导的 EAE 在用携带 MOG35-55 肽的 Ig-MOG 治疗后可从疾病中恢复。然而,携带 PLP139-151 的 Ig-PLP1 诱导抗 MOG 抗体减少并加重 EAE。在此,我们表明 Ig-PLP1 特异性降低了产生保护性 IgG2a/b 抗 MOG 抗体的 B 细胞的频率。令人惊讶的是,这些细胞是边缘区(MZ),而不是滤泡(FO)或新形成的(NF)B 细胞,并且将 MZ B 细胞转移到患病小鼠中以补体依赖的方式消除了 Ig-PLP1 引起的疾病加重。这些发现揭示了一种潜在的自身限制的调节机制,涉及 MOG EAE 中的自身抗体。